This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section focuses on legislation moving through Congress. It mentions legislation such as American Cures Act, committees such as Committee on Appropriations, members such as Richard Joseph Durbin.
Issued
May 12, 2026
senate side of the record
People
1
Linked members mentioned in this section
Legislation
1
Bills and resolutions linked from this section
Committees
1
Committees connected to this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
People mentioned
Bills and resolutions
Committees
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official Senate Record PDFReturn to issue contextBy Mr. DURBIN (for himself, Mr. Blumenthal, Ms. Duckworth, and
Mr. Van Hollen):
S. 4494. A bill to prioritize funding for an expanded and sustained national investment in biomedical research; to the Committee on Appropriations.
Mr. DURBIN. Mr. President, I ask unanimous consent that the text of the bill be printed in the Record.
S. 4494
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “American Cures Act”.
SEC. 2. APPROPRIATIONS FOR INNOVATION.
(a) In General.—There are hereby authorized to be
appropriated, and appropriated, out of any monies in the
Treasury not otherwise appropriated, the following:
(1) National institutes of health.—For the National
Institutes of Health at the Department of Health and Human
Services—
(A) for fiscal year 2027, $52,467,132,000;
(B) for fiscal year 2028, $56,507,101,164;
(C) for fiscal year 2029, $60,858,147,954;
(D) for fiscal year 2030, $65,544,225,346;
(E) for fiscal year 2031, $70,591,130,698;
(F) for fiscal year 2032, $76,026,647,762;
(G) for fiscal year 2033, $81,880,699,640;
(H) for fiscal year 2034, $88,185,513,512;
(I) for fiscal year 2035, $94,975,798,052;
(J) for fiscal year 2036, $102,288,934,502; and
(K) for fiscal year 2037 and each fiscal year thereafter,
the amount appropriated under this paragraph for the previous
fiscal year, increased by the percentage increase (if any),
during the previous fiscal year, in the Consumer Price Index
for all urban consumers published by the Bureau of Labor
Statistics.
(2) Centers for disease control and prevention.—For the
Centers for Disease Control and Prevention at the Department
of Health and Human Services—
(A) for fiscal year 2027,$ 9,911,621,307;
(B) for fiscal year 2028, $10,674,816,148;
(C) for fiscal year 2029, $11,496,776,991;
(D) for fiscal year 2030, $12,382,028,819;
(E) for fiscal year 2031, $13,335,445,038;
(F) for fiscal year 2032, $14,362,274,306;
(G) for fiscal year 2033, $15,468,169,428;
(H) for fiscal year 2034, $16,659,218,474;
(I) for fiscal year 2035, $17,941,978,296;
(J) for fiscal year 2036, $19,323,510,625; and
(K) for fiscal year 2037 and each fiscal year thereafter,
the amount appropriated under this paragraph for the previous
fiscal year, increased by the percentage increase (if any),
during the previous fiscal year, in the Consumer Price Index
for all urban consumers published by the Bureau of Labor
Statistics.
(3) Research, development, test, and evaluation program of
the department of defense health program.—For the research,
development, test, and evaluation program of the Department
of Defense health program—
(A) for fiscal year 2027, $2,939,358,093;
(B) for fiscal year 2028, $3,165,688,666;
(C) for fiscal year 2029, $3,409,451,694;
(D) for fiscal year 2030, $3,671,979,474;
(E) for fiscal year 2031, $3,954,721,894;
(F) for fiscal year 2032, $4,259,235,480;
(G) for fiscal year 2033, $4,587,196,612;
(H) for fiscal year 2034, $4,940,412,751;
(I) for fiscal year 2035, $5,320,824,534;
(J) for fiscal year 2036, $5,730,508,023; and
(K) for fiscal year 2037 and each fiscal year thereafter,
the amount appropriated under this paragraph for the previous
fiscal year, increased by the percentage increase (if any),
during the previous fiscal year, in the Consumer Price Index
for all urban consumers published by the Bureau of Labor
Statistics.
(4) Medical and prosthetics research program of the
department of veterans affairs.—For the medical and
prosthetics research program of the Department of Veterans
Affairs—
(A) for fiscal year 2027, $1,071,765,000;
(B) for fiscal year 2028, $1,096,132,905;
(C) for fiscal year 2029, $1,180,535,138;
(D) for fiscal year 2030, $1,271,436,344;
(E) for fiscal year 2031, $1,369,336,942;
(F) for fiscal year 2032, $1,474,775,887;
(G) for fiscal year 2033, $1,588,333,630;
(H) for fiscal year 2034, $1,710,636,320;
(I) for fiscal year 2035, $1,842,355,321;
(J) for fiscal year 2036, $1,984,218,681; and
(K) for fiscal year 2037 and each fiscal year thereafter,
the amount appropriated under this paragraph for the previous
fiscal year, increased by the percentage increase (if any),
during the previous fiscal year, in the Consumer Price Index
for all urban consumers published by the Bureau of Labor
Statistics.
(b) Availability.—Amounts appropriated under subsection
(a) shall remain available until expended.
(c) Definitions.—In this section:
(1) Centers for disease control and prevention.—The term
“Centers for Disease Control and Prevention” means the
appropriations accounts that support the various institutes,
offices, and centers that make up the Centers for Disease
Control and Prevention.
(2) Research, development, test, and evaluation program of
the department of defense health program.—The term
“research, development, test, and evaluation program of the
Department of Defense health program” means the
appropriations accounts that support the various institutes,
offices, and centers that make up the research, development,
test, and evaluation program of the Department of Defense
health program.
(3) Medical and prosthetics research program of the
department of veterans affairs.—The term “medical and
prosthetics research program of the Department of Veterans
Affairs” means the appropriations accounts that support the
various institutes, offices, and centers that make up the
medical and prosthetics research program of the Department of
Veterans Affairs.
(4) National institutes of health.—The term “National
Institutes of Health” means the appropriations accounts that
support the various institutes, offices, and centers that
make up the National Institutes of Health.
(d) Exemption of Certain Appropriations From
Sequestration.—
(1) In general.—Section 255(g)(1)(A) of the Balanced
Budget and Emergency Deficit Control Act (2 U.S.C.
905(g)(1)(A)) is amended by inserting after “Advances to the
Unemployment Trust Fund and Other Funds (16-0327-0-1-600).”
the following:
“Appropriations under the American Cures Act.”.
(2) Applicability.—The amendment made by this section
shall apply to any sequestration order issued under the
Balanced Budget and Emergency Deficit Control Act of 1985 (2
U.S.C. 900 et seq.) on or after the date of enactment of this
Act.
(e) Budgetary Effects.—
(1) Statutory paygo scorecards.—The budgetary effects of
this section shall not be entered on either PAYGO scorecard
maintained pursuant to section 4(d) of the Statutory Pay-As-
You-Go Act of 2010 (2 U.S.C. 933(d)).
(2) Senate paygo scorecards.—The budgetary effects of this
section shall not be entered on any PAYGO scorecard
maintained for purposes of section 4106 of H. Con. Res. 71
(115th Congress).